Plasmodium gametocytes lack apical-basal polarity

Serial block-face scanning electron microscopy (SBF-SEM) generates high-resolution 3D images of larger sample volumes at ~50 nm resolution [10, 11]. We employed SBF-SEM to obtain a detailed map of membrane organization and organelle placement across gametocyte development (Fig 1). The cellular features are revealed in individual SBF-SEM “sections” (Fig 1 top panels). Rendering of these features in successive sections provides a 3D view of parasite ultrastructure (Fig 1 bottom panels). Features such as the RBC membrane (RBC), parasite plasma membrane/parasitophorous vacuole membrane (PM, blue) and nucleus (N, yellow) are readily identified. From late stage II gametocytes the mitochondrion (M, red) can be seen in addition to the apicoplast (A, orange) (Fig 1D–1H). Mature stage IV and V gametocytes have osmophillic bodies (Ob, light blue) (Fig 1G and 1H). These are best appreciated by viewing the translations through the SBF-SEM sections (S1–S3 Videos) and the 3D rotations of the 3D rendered images (S4–S6 Videos). Parasite elongation (length to width ratio) reached a maximum value (4.6) at stage IV, and then decreased (3.3) at stage V. Nuclear elongation reached a maximum value (3.3) at stage III, then decreased at stage V (1.2). Mitochondrial elongation reaching a maximum value (3.5) at stage IV, then decreased at stage V (1.4) (S1 Fig). Analysis of 35 individual stage III/IV gametocytes revealed no evidence for apical-basal polarity, as is observed in the invasive or motile stages of development (merozoites, sporozoites and ookinetes) where the IMC is also present. That is, there is no apical complex, the nucleus was roughly centrally located, and we observed a roughly even distribution of the mitochondrion and digestive vacuole complex with respect to the two ends and two sides of the cell (Supp S2 Fig, S1 Table).

Download:

• PPT
  PowerPoint slide
• PNG
  larger image
• TIFF
  original image

Fig 1. Whole cell reconstructions reveal organelle organization during gametocyte development.

(A-H) Individual SBF-SEM images of different stages (top rows), and rendered images of serial SBF-SEM sections (bottom rows). The following structures are labeled in the sections and color-coded in the rendered images. Parasite plasma membrane/parasitophorous vacuole membrane (PM, blue), mitochondrion (M, red), nucleus (N, yellow), hemozoin (Hz), the apicoplast (A, orange), osmophillic bodies (OB, light blue), Dimples (Di) and RBC. Scale bars: 5 μm. The dotted line marks the plane of sectioning. Rotations of these models and translations through the SBF-SEM images can be seen in S1–S6 Videos. Quantitative measurements and relative organelle positions are presented in S1 and S2 Figs and S1 Table.

https://doi.org/10.1371/journal.ppat.1006659.g001

The IMC expands via addition of membrane to the leading edge of the plates

We next investigated IMC formation by SBF-SEM. The phospholipid-rich (double membrane) nature of the IMC promotes binding of the reduced osmium stain, thus permitting its detection by intensity thresholding and semi-automatic segmentation (Fig 2; see S1–S6 Videos). In early stage II gametocytes, regions of thickened membranes are observed (Fig 2A, SBF-SEM section, yellow arrow). Rendering of this structure reveals a narrow semi-circular strip of thickened membrane at the parasite periphery (Fig 2A, purple, yellow arrow). Pockets of deposited membrane material are also observed in other regions of the cell (Fig 2A, blue arrow). The zoom image shows the formation of a disk-like structure (Fig 2A, zoom, yellow arrow). As the parasite elongates to the “lemon-shaped” stage IIb, the initial line of membrane expands to form a ribbon (Fig 2B, yellow arrow). The striped appearance of the IMC is already evident at this stage (Fig 2B zoom, yellow arrow IMC plates). By stage III, the IMC begins to expand and wraps further around the parasite (Fig 2C and 2D). Regions of extra thick membrane are evident along the growing edge of the IMC (Fig 2C and 2D, yellow arrow and zooms). These membrane thickenings are seen within the SBF-SEM sections (Fig 2C and 2D, yellow arrows). This suggests that the IMC plates are extended laterally by deposition of membrane material at the leading edge. By stage IV, the parasite is almost completely enclosed by the IMC and elongation is most pronounced (Fig 2E). Rotations at 0 and 90° of the rendered model highlight the structure of the IMC plates and the expansion of the IMC structure (Fig 2E, yellow arrows). These rotations illustrate the opening where the IMC plates have not fused (Fig 2E, 90° white arrow and see S6 Video for rotations). Our 3D-SIM analysis revealed that the IMC is made up of 13 cisternal plates in total of which the two end plates are larger. Examination of the SBF-SEM reveal that the 11 internal plates (Fig 2E, yellow arrow) have an average width of 0.85 ± 0.27 μm, while the 2 plates near the tips of the gametocytes (Fig 2E, blue arrow) have an average width of 2.2 ± 1.6 μm. By stage V the ends of the parasite are rounded and the IMC stripes are no longer evident in SBF-SEM (Fig 2F), potentially due to a relaxing of the gametocyte upon disassembly of the microtubule network. Indentations of the parasite surface and IMC, which occur during fixation, may represent areas of weakness in the IMC and parasite plasma membrane, as the microtubule skeleton is disassembled, in the mature stage V parasite (S3 and S6 Videos).

Download:

• PPT
  PowerPoint slide
• PNG
  larger image
• TIFF
  original image

Fig 2. The IMC is expanded from the leading edge.

(A-F) SBF-SEM showing the organization and genesis of the IMC plates at the gametocyte periphery. Rendered models (right) and individual SBF-SEM sections (left) are shown. The IMC is identified as an electron-scattering structure at the parasite periphery. The rendered 3D models reveal (A) a narrow semi-circular strip of thickened membrane at the periphery of stage II gametocytes (yellow arrow), transitioning (B) to a ribbon of disc-like plates in stage IIb (yellow arrow). (C-D) In stage III of development, these plates have expanded. Regions of thickening (yellow arrow, rendered in white) are observed at the leading edges of these plates. These may represent regions where new membrane is being deposited. (E) The plates of the IMC are clearly visible in stage IV gametocytes (yellow arrow). (F) Stage V gametocyte showing the relaxed IMC membrane. Rendered models show the Parasite Plasma Membrane (PPM, blue) and the Inner Membrane Complex (IMC, magenta). Scale bars: 5 μm. 5x Zoom images are shown on the right. Scale bars: 1 μm. SBF-SEM sections and rotations of the rendered models are presented in S1–S6 Videos.

https://doi.org/10.1371/journal.ppat.1006659.g002

PhIL1 is a component of the IMC in P. falciparum

To further study IMC genesis and organization, we characterized the P. falciparum homologue (PF3D7_0109000.1) of T. gondii PhILl, which shares 56% sequence identity within the C-terminal region (amino acids 130–217). S3 Fig provides a protein alignment of the sequences for a number of PhIL1 homologues in EupathDB. The N-terminal region is highly divergent and contains a motif (amino acids 17–91) that is found in non-muscle myosins. To study the cellular location of PhIL1 a recombinant protein corresponding to full-length PhIL1 (predicted molecular mass of 25,477 Da), was expressed in E. coli and used to generate rabbit polyclonal antiserum. Immunofluorescence microscopy of stage IV gametocytes revealed a strong PhIL1 signal at the periphery, where it is closely associated with β-tubulin (Fig 3A) and was located close to the known IMC marker, the glideosome-associated protein 50 (GAP50) (Fig 3B). Likewise, PhIL1 was found at the IMC in late stage schizonts (S4A and S4B Fig). The specificity of the immune serum is indicated by its recognition of a single band of ~28 kDa in Western blots of the pellet fraction of saponin-permeabilized gametocytes (3D7 WT and GAP50-GFP transfectants, Fig 3C). No bands were observed when protein extracts were probed with pre-immune sera (Fig 3C). This sample was also positive for the IMC marker, GAP45 (Fig 3C). Probing with anti-GFP confirmed the correct expression of the GAP50-GFP chimeric protein and the ER marker PfERC was used as a loading control (Fig 3C; see S10 Fig for full-length blots).

Download:

• PPT
  PowerPoint slide
• PNG
  larger image
• TIFF
  original image

Fig 3. PhIL1 is located at the IMC in gametocytes.

(A) Immunofluorescence microscopy showing anti-PhIL1 (green) at the periphery of a 3D7 stage IV gametocyte, showing fluorescence close to the anti-β-tubulin (red) labeling. (B) Immunofluorescence microscopy of a stage IV gametocyte showing overlap of GAP50-GFP (red) and PhIL1 (green) at the periphery of the cell. (C) Western blot analysis of saponin-treated pellets of 3D7 and GAP50-GFP stage IV gametocytes. Gametocytes were probed with PhIL1 pre-immune serum, anti-PhIL1 antiserum, anti-GAP45, anti-GFP and anti-ERC. (D, E) Immunofluorescence microscopy of stage IV PhIL1-GFP (D) and PhIL1-HA (E) gametocyte transfectants. Parasites were labeled with anti-PhIL1 (green) and anti-GFP or anti-HA (red). Nuclei were labeled with DAPI. Scale bars: 5 μm. (F) Purified, saponin-lysed PhIL1-HA gametocytes were solubilized with different extraction agents for 30 min. Pellet and supernatant fractions were separated and loaded in equivalent amounts on 4–12% acrylamide gels. PhIL1 and GAP45 bands were visualized using mouse anti-HA or rabbit anti-GAP45 primary and HRP-conjugated goat anti-mouse or goat anti-rabbit secondary antibodies, respectively. P = pellet; S = supernatant. Western analysis and immunofluorescence of PhIL1 is presented in S3 Fig.

https://doi.org/10.1371/journal.ppat.1006659.g003

To further investigate the location of PhIL1 in P. falciparum we generated transgenic parasites in which full length GFP-tagged PhIL1 was episomally expressed under the control of the gametocyte-specific Pfs16 promoter (PhIL1-GFP) [12]. A PhIL1-HA line was also generated by integrating 3xHA into the 3’ end of the PhIL1 locus. Immunofluorescence signals for HA and GFP overlapped with the signal from anti-PhIL1 antibody, confirming the correct location of the tagged proteins (Fig 3D and 3E). Western blotting of extracts of transfected gametocytes with anti-PhIL1, anti-GFP and anti-HA revealed the expected bands of 28–30 kDa in the PhIL1-HA line (which sometime appeared as a doublet), and 48 kDa in the PhIL1-GFP line (S4C Fig). Both samples were positive for PfERC (S4C Fig).

The PhIL1 antiserum recognizes a band of ~28 kDa in schizont stage asexual parasites, plus a possible breakdown product at ~20 kDa (S4C Fig). Immunofluorescence microscopy revealed a signal at the periphery of merozoites in very late stage schizont-infected RBCs and in free merozoites (S4A and S4B Fig), colocating with the IMC marker GAP45 (S4B Fig). No PhIL1 signal was observed in ring and trophozoite-infected RBCs and no fluorescence signal was observed with the pre-immune serum.

Saponin-permeabilized PhIL1-HA gametocytes were subjected to solubility profiling using different extraction agents. PhIL1 was only partially extracted with carbonate buffer and Triton X-100, but fully extracted in 8M urea and 2% SDS. This is suggestive of an association with the cytoskeleton and peripheral association with the IMC (Fig 3F). Blots were re-probed with anti-GAP45 to validate the solubility profile (Fig 3F) [9].

Arrangement and organisation of the IMC membrane plates and microtubules at different stages of gametocyte development

To investigate the formation and expansion of the IMC we made use of the PhIL1-HA parasite line and performed 3D-SIM super-resolution microscopy at different stages of early gametocyte development. The initial phase of IMC formation (in stage I) is associated with the deposition of a semi-circular ribbon of PhIL1 at the parasite periphery (Fig 4A, yellow arrow). Co-staining with anti-β-tubulin antiserum reveals punctate buds that form an alternating pattern within the PhIL1 ribbon (Fig 4A, blue arrow). Puncta of β-tubulin are also observed in other regions of the cell; these may represent microtubule “seeds” (Fig 4A). The spatial organization of the PhIL1 and β-tubulin puncta are best appreciated in the zoom in images (Fig 4A, zoom) and in the 3D rotations of the 3D-SIM images (S7 Video). As the cell transitions to stage II, the PhIL1 puncta form 13 small circular structures that represent the nascent IMC plates (Fig 4B, yellow arrow. S7 Video). An accumulation of β-tubulin is observed at the center of each of these nascent plates (Fig 4B, blue arrow, zoom). The data indicate that the nascent IMC plates may stabilize microtubule nuclei, thereby promoting microtubule polymerization and growth; however it is also possible that IMC assembly is driven by microtubule polymerization.

Download:

• PPT
  PowerPoint slide
• PNG
  larger image
• TIFF
  original image

Fig 4. Genesis and development of the gametocyte IMC.

(A-G) 3D-SIM immunofluorescence microscopy reveals the location of PhIL1-HA (red) relative to β-tubulin (green) for PhIL1-HA gametocytes from stage I-V of development. (A) A row of PhIL1-HA labeled puncta (yellow arrow) is observed along one edge of the parasite, interleaved with β-tubulin staining (blue arrow). (B) In stage II gametocytes, PhIL1-HA is observed as 13 ring-like structures (yellow arrows) aligned at the periphery of the parasites. Accumulations of β-tubulin staining can be seen in the centers of these disks (blue arrow). (C) The nascent IMC plates are more homogenously labeled with PhIL1-HA (yellow arrow), forming a ribbon-like structure at the periphery of the cell. Microtubules align with the IMC plates (blue arrow) or cross the parasite cytoplasm (white arrow). (D-E) In stage III, the IMC plates are clearly defined with homogenous PhIL1-HA labeling (yellow arrow). Bundles of microtubules underlie the IMC (blue arrow) or cross the parasite cytoplasm (white arrow). (F) In stage IV gametocytes, the IMC largely encases the parasite. The PhIL1-HA plates (yellow arrow) are still clearly visible and the microtubule network is tightly associated with the IMC (blue arrow). (G) By stage V, the microtubule network is disassembled but the IMC (labeled with PhIL1-HA) remains at the parasite periphery (yellow arrows; sutures are indicated with white arrows). 5x and 2.5X zoom images are shown on the right hand side. Scale bars: 5 μm. Scale bars: zoom images: 1 μm. The represented area is marked on the images with a white box. Rotations of these 3D-SIM images are provided in S7 and S8 Videos.

https://doi.org/10.1371/journal.ppat.1006659.g004

As the gametocyte develops further, bundles of microtubules extend along the nascent plates (Fig 4C, blue arrow). In addition, extended microtubules are observed traversing the parasite cytoplasm (Fig 4C, white arrow). Electron microscopy analysis of freeze-substituted stage II-III gametocytes confirms that microtubules lie closely opposed to the IMC (S5A Fig, yellow arrows) as well as crossing the cytoplasm (S5B Fig, blue arrows).

In stage III gametocytes, the IMC plates expand laterally (Fig 4D and 4E, yellow arrow). The leading edge of the IMC can be seen at the tip of the gametocyte with closely associated β-tubulin (Fig 4D, zoom). The parasite starts to elongate due to the formation of extended microtubules underneath the IMC plates (Fig 4D and 4E, blue arrow) and in the regions away from the IMC plates crossing the parasite cytoplasm (white arrow). The organization of the IMC plates, the sutures (white arrows) and microtubules can be seen in the zoom image of Fig 4E.

The expansion of the IMC plates is completed in stage IV where they almost cover the entire parasite, with a small opening present where the plates have not yet fused (Fig 4F; best appreciated by examining the rotation of the 3D-SIM images; S8 Video). The stage IV microtubules are all tightly associated with the IMC, forming a dense network (Fig 4F, blue arrow, zoom). Electron microscopy reveals long continuous microtubules running the length of the gametocyte (S5E Fig, blue arrows) and arranged in a tightly packed array at the tips of the stage IV gametocyte (S5E and S5F Fig, yellow arrows).

In stage V of development, the microtubule skeleton is depolymerized, leaving only a weak, diffuse labeling with anti-β-tubulin (Fig 4G). The plates of the IMC are still visible delineated by the darker suture lines (Fig 4G, zoom). Electron microscopy of stage V gametocytes reveals the presence of small microtubule stubs bound to the IMC, often in small bundles (S5G and S5H Fig, yellow arrows). This depolymerisation of the microtubules coincides with the previously reported increase in cellular deformability at stage V of development [13, 14].

Genetic attenuation of PhIL1 arrests gametocyte development

To assess the function of PhIL1, we generated an inducible gene knockdown using the glmS riboswitch system [15, 16]. Integration of the PhIL1-HA-glmS plasmid into the endogenous PhIL1 locus in NF54 parasites was confirmed by PCR (S6A and S6B Fig). Immunofluorescence microscopy confirmed the location of PhIL1-HA at the gametocyte periphery where it overlaps with β-tubulin (Fig 5A). Treatment of PhIL1-HA-glmS parasites with glucosamine was performed for 6 days from a ring stage culture containing both asexual and gametocyte rings. Apparent knockdown of PhIL1-HA to a level of 85% (by densitometry) was achieved with 5 mM glucosamine (Fig 5B). Knock-down was associated with a 62% reduction (t-test, P = 0.001) in the numbers of gametocytes (Fig 5C) and the remaining gametocytes had significantly altered morphology (Fig 5D and 5E, S6D Fig). In wildtype NF54 parasites or in untreated PhIL1-HA-glmS parasites, more than 75% of the parasites reach stage IV/V by day 7 (Fig 5E, S6C Fig), while less than 15% of the remaining gametocytes in the treated PhIL1-HA-glmS line have progressed morphologically past stage III (Fig 5E). Untreated PhIL1-HA-glmS transfectants reached an average cell length of 10.3 ± 0.3 μm by day 6, similar to the treated or untreated NF54 (S6F Fig). By contrast, glucosamine-treated PhIL1-HA-glmS parasites had an average length of only 4.9 ± 0.4 μm. Taken together these data indicate that PhIL1 is needed for gametocytes to progress morphologicaly past stage III of development. By contrast, treatment of asexual stage parasites with 5 mM glucosamine had no effect on parasite growth (S7A Fig), demonstrating that PhIL1 is not needed (or needed only at low level) for asexual reproduction. Immunofluorescence analysis of the late stage marker Pfs48/45 indicated that this protein in produced in the few PhIL1 knock-down parasites that survive treatment with glucosamine (S7B Fig).

Download:

• PPT
  PowerPoint slide
• PNG
  larger image
• TIFF
  original image

Fig 5. Knockdown of PhIL1 arrests gametocyte development.

(A) PhIL1-HA-glmS (green) is located at the parasite periphery, closely associated with β-tubulin (red). (B) Stage IV PhIL1-HA-glmS gametocytes treated with a range of glucosamine concentrations and analyzed by Western blotting. Probing with anti-HA shows efficient knockdown of the PhIL1-HA protein when compared to the anti-PfERC loading control. (C) Glucosamine-treated (+GLCN, 5 mM) and untreated (-GLCN, 0 mM) cultures were induced to form gametocytes and the parasitemia estimated at day 6. Data represent mean ± SEM; n = 3 experiments performed in triplicate. *** P <0.001, unpaired t-test. (D) Representative Giemsa-stained smears highlighting the altered morphology following PhIL1 knockdown. (E) Stage progression counts for PhIL1-HA-glmS parasites plus or minus glucosamine, highlighting the arrest in development following knockdown. Days 3, 5 and 7 only are shown. The complete data set, including wild type parasites plus or minus glucosamine, are presented in S6C and S6D Fig. Data from 2 separate experiments performed in triplicate. Mean values are shown. (F) SBF-SEM images of PhIL1-HA-glmS parasites, plus or minus glucosamine. Rendered models are shown on the left, highlighting the IMC in purple and the digestive vacuole in green. A swollen digestive vacuole (DV; yellow arrow) is observed in glucosamine-treated parasites. Scale bars: 5 μm. (G) Quantification of the SBF-SEM images. Mean volumes for the parasite and the digestive vacuole are shown. Data represent mean ± SEM. n = 5. ** P <0.01, unpaired t-test. (H) PhIL1-HA-glmS parasites plus or minus glucosamine were labeled with LysoSensor to highlight the acidic digestive compartments. Swollen compartments are seen in the treated group, but not in the untreated control group (blue arrows).

https://doi.org/10.1371/journal.ppat.1006659.g005

Immunofluorescence microscopy of PhIL1-HA-glmS reveals that GAP45 and β-tubulin are still located at the periphery of the knockdown parasites, suggesting that the initial stages of formation and attachment of the microtubules to the IMC are not affected (S6E Fig). SBF-SEM imaging confirmed the presence of the IMC, however the width of the plates was less than in the untreated controls, suggesting an inability of the IMC plates to expand (Fig 5F). A striking feature of the PhIL1-HA-glmS knockdown parasites was a greatly enlarged digestive vacuole (Fig 5F). While the parasite volume remained roughly similar (untreated, 45.2 ± 6.1 fL; treated, 51.4 ± 6 fL), the DV volume was markedly increased (Untreated, 1.9 ± 0.2 fL; treated, 10.8 ± 1.9 fL; P = 0.01) (Fig 5G). This may suggest mistrafficking of membrane destined for IMC expansion. Similarly, labeling live gametocytes with the pH-reporter, LysoSensor, reveals small, evenly distributed acidic compartments in control gametocytes and swollen acidic compartments in treated parasites (Fig 5H).

PhIL1 co-precipitates with key IMC components

To identify PhIL1-interacting proteins, we solubilized PhIL1-GFP stage IV gametocytes using Triton X-100 and performed immunoprecipitation using GFP-Trap. The IMC proteins, GAP45 and GAP50 were significantly enriched in the pull-down from the PhIL1-GFP transfectants, when compared to wildtype 3D7 (Fig 6A). To investigate PhIL1-interacting partners more globally, immunoprecipitated proteins were subjected to in-solution trypsin digestion and analysed by liquid chromatography-tandem mass spectrometry (LC-MS/MS). We identified eight parasite proteins that were significantly enriched (≥2 significant MS/MS spectra in two independent experiments) in PhIL1-GFP compared to wildtype 3D7 (Fig 6B, S2 Table). Precipitated proteins included PhIL1 itself, GAP50, two members of the glideosome-associated protein with multiple membrane spans (GAPM)1 and GAPM2, and Heat Shock Protein 110c (HSP110c) (Fig 6B, S2 Table). In addition, we identified three previously uncharacterized proteins PF3D7_1355600, PF3D7_1431100 and PF3D7_1430800, which we have termed PhIL1 Interacting Proteins (PIPs)1-3 respectively (Fig 6B, S2 Table). PIP1 appears to be restricted to human malaria species with no homologue identified in the rodent malaria species, nor in Toxoplasma. Interrogation of transcriptional data (PlasmoDB) indicates that PIP1 is more highly transcribed in gametocytes than in asexual parasites [17]. In contrast, PIP2 and -3 are found in all malaria species, and exhibit low level similarity to the T. gondii alveolin domain-containing intermediate filament proteins, IMC7 and IMC12 (Fig 6B, S2 Table). PIP2 and PIP3 have been previously identified as putative IMC proteins [18]. Interactions with other known IMC and cytoskeleton proteins were also observed, including GAP40, GAP45, GAPM3, IMC1c, β-tubulin and actin-I, as well as with several uncharacterized proteins, but these failed to reach the applied significance criteria. A full list of identified proteins is provided in S2 Table.

Download:

• PPT
  PowerPoint slide
• PNG
  larger image
• TIFF
  original image

Fig 6. Identification of new IMC proteins in gametocytes.

(A) 3D7 parent and PhIL1-GFP transfectant gametocytes, purified at stage IV, were detergent-solubilized and proteins were immunoprecipitated using GFP-Trap. The input and precipitated eluates (IP) were prepared for SDS-PAGE and Western blot and probed with anti-GFP, anti-GAP50 and anti-GAP45 antibodies. Molecular masses of markers are shown in kDa. (B) List of the PhIL1-interacting proteins. Two independent experiments were performed. Proteins that returned ≥2 significant MS/MS peptides in each experiment are included. A complete list of significant and non-significant proteins identified are presented in S2 Table.

https://doi.org/10.1371/journal.ppat.1006659.g006

Characterization of PhIL1 interacting protein-1 (PIP1)

We generated a parasite line expressing a HA-glmS fusion of the top PhIL1 interacting protein (PF3D7_1355600; PIP1). Integration was confirmed by PCR (S8A and S8B Fig) and the expected band of ~66 kDa was observed in Western blots of both asexual and sexual stage parasites (S8D Fig). Immunofluorescence microscopy revealed that PIP1-HA is present at the IMC during early stages of development, where it largely co-locates with PhIL1 (Fig 7A). PIP1-HA extends completely around the parasite periphery by stage III of development (Fig 7A, top panels), but following transition to stage IV it is depleted from the tips of the gametocyte (Fig 7A, yellow arrows), and wanes significantly in stage V gametocytes (Fig 7A, bottom panel). Immunofluorescence microscopy reveals that PIP1-HA is located at the periphery of the nascent merozoites within late stage schizonts, in a similar location to PhIL1 (S8C Fig).

Download:

• PPT
  PowerPoint slide
• PNG
  larger image
• TIFF
  original image

Fig 7. PhIL1-interacting protein, PIP1, is located at the gametocyte IMC and is essential for gametocyte development.

(A) PIP1-HA-glmS transfectants were labeled with anti-PhIL1 rabbit (green) and anti-HA (red) at different developmental stages (II–V). Nuclei were labeled with DAPI. There is an apparent reduction in fluorescence intensity of PIP1-HA labeling at the tips of the gametocyte in stage IV (yellow arrow). In stage V, the fluorescence becomes punctate at the parasite periphery, while PhIL1 remains homogenous. (B) 3D-SIM imaging of PIP1-HA-glmS during gametocyte development. Homogeneous labeling of the IMC plates by anti-HA (red) are observed (yellow arrows) in the early stages of development. During stage III–IV of development, there is a loss of labeling from the plates near the tips of the elongated parasite (blue arrows), with some protein labeling of the tips themselves (white arrows). Scale bar: 5 μm. (C) Western blot analysis of saponin-treated pellets of harvested PIP1-HA-glmS plus or minus glucosamine. Probing with anti-HA antibodies shows a robust knockdown of PIP1-HA protein. (D) Parasitemia was calculated from Giemsa smears of PIP1-HA-glmS parasites plus or minus glucosamine. Data represent mean ± SEM. n = 3 experiments performed in triplicate. ** P <0.01, unpaired t-test. (E) Representative parasites from the Giemsa smears showing altered morphology following PIP1 knockdown. (F) Analysis of Giemsa smears from days 3, 5 and 7 showing a loss of morphologically normal parasites. The complete data set including wild type parasites plus or minus glucosamine are presented in S9C and S9D Fig. Data from 2 separate experiments performed in triplicate. Mean values are shown.

https://doi.org/10.1371/journal.ppat.1006659.g007

3D-SIM confirmed that PIP1 is associated with IMC plates in stage II—IV gametocytes (Fig 7B, yellow arrows). However, the plates closest to the gametocytes tip lose PIP1 fluorescence from stage III (Fig 7B, blue arrows). Some PIP1 fluorescence is retained at the apex of the tips in stage IV gametocytes (Fig 7B, white arrows). This is in contrast to PhIL1, which remains associated with all of the IMC plates throughout development (Fig 3B and 3E).

To confirm the interaction of PIP1 with PhIL1 we immunoprecipitated extracts of wild type 3D7 and PIP1-HA-glmS parasites, using anti-HA agarose beads. The precipitated proteins were subjected to in-solution tryptic digestion and analysed by mass spectrometry. This analysis identified PhIL1 as the top interacting protein, thus confirming this interaction. PIP2 and GAPM2 were also enriched (≥2 significant MS/MS spectra in two independent experiments) (S9F Fig and S2 Table). Other proteins enriched in one of the two experiments include PIP3, GAP50, GAP45 and α-tubulin II (S2 Table).

Treatment of the PIP1-HA-glmS parasites with 5 mM glucosamine was associated with ~90% apparent knockdown (Fig 7C). Immunofluorescence microscopy confirms the loss of the PIP1-HA signal (S8E Fig). Knockdown was associated with a 68% reduction in gametocyte numbers on day 6 of the gametocyte assay (P = 0.01) (Fig 7D), and an apparent arrest of development (Fig 7E). While the late stage marker Pfs48/45 is produced, less than 10% of the surviving PIP1-depleted parasites achieved stage IV morphology by day 7, compared with >50% of untreated parasites (Fig 7F, S9 Fig). The average parasite length decreased from 10.5 ± 0.5 μm to 5.2 ± 0.4 μm in the glucosamine-treated group (S9C Fig). As with PhIL1, electron microscopy revealed arrested development of the IMC and swelling of the digestive vacuole in the knockdown cell line (S9D Fig). Quantification of the SBF-SEM images showed no significant difference in the glucosamine-treated (46.6 ± 1.8 fL) and untreated (42.3 ± 2.3 fL) parasite volumes but a significant increase in the digestive vacuole volume following glucosamine treatment (untreated 0.9 ± 0.2 fL; treated 8.5 ± 2 fL; P = 0.01) (S9E Fig). By contrast, treatment of the parental 3D7 line with 5 mM glucosamine had no effect on gametocyte development (S9A Fig). Similarly, treatment of asexual PIP1-HA-glmS parasites had no significant effect on parasite growth (S9G Fig), suggesting that PIP1 is not essential (or only needed at a low level) for asexual replication.

Parasite culture

Asexual stage parasites were grown in O+ RBCs (Australian Red Cross blood service) at 5% hematocrit. The parasites were maintained in complete culture media containing RPMI-GlutaMAX-HEPES (Invitrogen) supplemented with 5% v/v human serum (Australian Red Cross blood service), 0.25% w/v AlbuMAX II (Invitrogen), 200 μM hypoxanthine, 10 mM D-glucose (Sigma) and 20 μg/ml gentamicin (Sigma). To obtain ring stage cultures sorbitol (5%) synchronization was performed [37]. Transfectants were maintained in media supplemented with WR99210 (5 nM). High gametocyte producing NF54 and 3D7 parasite lines were used [38, 39].

Gametocytes were generated as previously described [13, 40, 41]. Asexual stage parasites were sorbitol synchronized to produce a ring stage culture and the parasitemia adjusted to 3% parasitemia at 5% hematocrit (day -4). The culture was grown in complete culture media until day -1 resulting in a culture containing 8–10% trophozoite stage parasites. The culture was adjusted to 2% parasitemia 5% hematocrit by addition of fresh media and RBCs. The spent culture media was left on the culture at a ratio of 1:4 with fresh media to induce gametocyte induction. N-acetyl-D-glucosamine (GluNac; 62.5 mM final concentration) was added from day 0 of the culture [40]. This protocol results in synchronized gametocyte production. Gametocyte stage development was monitored by thin blood films and Giemsa staining. The following timing of stage progression is used as a guide but can vary depending on the cell line and age of asexual cells when the assay was established. Day 0–1: stage I; Day 2–3: stage II; Day 4–5: stage III, Day 6–7: stage IV; day 8 –onwards: stage V. Gametocytes were purified from culture at the required development stage by Percoll density gradient or magnet separation [40, 41].

Plasmid construction and transfection

The pPhIL1-3xHA plasmid was created by amplifying full length PhIL1 sequence from genomic 3D7 DNA with the P1FHA (GCAGATCTAAAATGCTTTCTTCCATATCACCAAAAAG) and P1RHA (AACTGCAGCCATATCTTGGTTATAATTTTCTTGATC) primers (restriction enzyme sites in bold). The resulting PCR product was directionally cloned into the BglII and PstI sites of the pD3HA plasmid. The pPfs16-PhIL1-GFP construct is an episomally maintained plasmid that utilizes the promoter region of the early gametocyte specific protein Pfs16 [12]. The full-length coding sequence of PhIL1 was amplified from genomic 3D7 DNA with the PIGFPF (GCGTCGACAAAATGCTTTCTTCCATATCACCAAAAAG) and PIGFPR (AACTGCAGTGCTGCTGCTGCTGCTGCTGCTGCCATATCTTGGTTATAATTTTCTTGATC) primers containing BglII and PstI restrictions sites respectively. This product was directionally cloned into the p16proPfs16-GFP Entry plasmid [12] which had been predigested with BglII and PstI to remove the Pfs16 coding sequence. The resulting plasmid pPfs16pro-PhIL1-GFP was recombined with the pHH1 Destination vector as previously described to obtain the pHH1-Pfs16pro-PhIL1-GFP plasmid [12].

The pGLMS-PhIL1-HA inducible knockdown construct was made as described above for the pPhIL1-3xHA plasmid, with cloning of the same full-length PhIL1 fragment into the pGlmS plasmid. To generate the pGlmS-PIP1-HA plasmids the coding sequence of PIP1 was PCR amplified from 3D7 genomic DNA using the PIPF (GTCGACGGATCCATGAATAACGGATCTAATAAA) and PIPR (CTGCAGTGCTCTTTTTTTAAATTGCATAGG) primers and directionally cloned into the pGLMS-HA plasmid using the BamHI and PstI restriction sites.

Parasite transfections were performed by electroporation as previously described [42]. Drug cycling was performed to enrich for integrated parasites. Integration of the lines was confirmed by PCR using the PHILINT (GAACCTTCCATAACAGAC) or PIPINT (CCGCGGCCTATATTATTTTCATTAAACATTGAC) primers that target genomic sequence upstream of the targeting sequence in combination with the vector specific HArev (CGAACATTAAGCTGCCATAT) reverse primer.

Recombinant protein and antibody production

A codon optimized (for E. coli) sequence of full length PhIL1 (PlamsoDB ID: PF3D7_0109000.1) was commercially synthesized by GenScript. This sequence was directionally cloned into the PstI and BglII sites of the pQE-30 protein expression plasmid, which will place a 6xHis tag at the N-terminus of the resulting protein. The plasmid was transformed into BL21 (DE3) E. coli (Bioline) and grown in the presence of 100 μg/ml Ampicillin. The expression of recombinant PhIL1 was induced with the addition of 2 mM isopropyl-D-1-thiogalactopyranosid (IPTG). After 3 h, cells were pelleted via centrifugation at 4,000 x g for 20 min at 4°C and the pellet was then re-suspended in lysis buffer (50 mM NaH₂PO₄, 300 mM NaCl, 10 mM imidazole, pH 8.0). Lysozyme (1 mg/mL) was also added and cells were incubated on ice for 30 min. The lysate was then sonicated and drawn through a 21-gauge syringe before being frozen at -80°C overnight. After thawing, the lysate was centrifuged at 10,000 x g for 20 min at 4°C and the supernatant containing the soluble protein fraction was discarded. The pellet was re-suspended in a denaturing lysis buffer (100 mM NaH₂PO₄, 10 mM Tris-Cl, 8 M urea, pH 8.0) and after a 1 h incubation period, the E. coli lysate was centrifuged at 10,000 x g for 20 min. His-tagged PhIL1 was purified from the supernatant fraction using a batch purification method.

The bacterial lysate was mixed with 50% Ni-NTA agarose resin for 1 h on a rotary mixer and then placed into a column. The agarose resin was washed three times using a wash buffer (100 mM NaH₂PO₄, 10 mM Tris-Cl, 8 M urea, pH 6.3). Recombinant PhIL1 was eluted using elution buffer A (100 mM NaH₂PO₄, 10 mM Tris-Cl, 8M urea, pH 5.9) and then elution buffer B (100 mM NaH₂PO₄, 10 mM Tris-Cl, 8 M urea, pH 4.5). All elution fractions were collected. Those containing PhIL1 protein were pooled and the buffer was exchanged for 1x PBS via dialysis. The resultant protein was then sent to the Walter and Eliza Hall Institute antibody facility, Bundoora. Rabbits were immunized to produce polyclonal antibodies against P. falciparum PhIL1.

Immunofluorescence microscopy

Glass coverslips were primed for immunofluorescence assays by incubating with 0.1 mg/mL PHAE (erythroagglutinating phytohemagglutinin, Sigma Aldrich) for 15–30 min in a humid chamber at 37°C [43]. Parasites were harvested by centrifugation at 2,000 x g for 2 min, washed in 1x PBS and placed onto the PHAE coated coverslip and incubated at room temperature for 15 min. Washing of samples with 1x PBS was carried out between each step of the following protocol. Cells were incubated on the slides and then fixed in a solution of 4% v/v paraformaldehyde and 0.0065% v/v glutaraldehyde. Parasite permeabilization was carried out using 0.1% Triton X-100. Immobilized cells were stained with primary antibodies for 1 h at room temperature (RT) (anti-PhIL1 rabbit (1:500), anti-HA rat (1:250, Sigma Aldrich) anti-HA mouse (1:250, Sigma Aldrich), anti-GAP45 rabbit (1:1000, [44]) anti-GFP mouse (1:500, Roche) anti-β-tubulin mouse (1:500, Sigma Aldrich), anti-Pfs16 mouse (1:1000, [12]). The secondary antibody was added for 1 h at RT (goat anti-mouse Alexa Fluor 488, 568, 647; anti-rabbit 488, 568, 647; anti-rat 647, were used at 1:250). Parasite nuclei were stained with DAPI (2 μg/mL) for 10 min at room temperature. The slides were mounted in p-phenylenediamine antifade and kept at 4°C. Samples were imaged on a DeltaVision Elite Restorative Widefield Deconvolution Imaging System (GE Healthcare) using the 100x UPLS Apo (1.4NA) objective lens under oil immersion. Samples were excited with solid state illumination (Insight SSI, Lumencor). The following filter sets with excitation and emission wavelengths were used: DAPI Ex390/18, Em435/48; FITC, Ex475/28, Em523/26; TRITC, Ex542/27, Em594/45; Cy5 Ex 632/22, 676/34 nm. For higher resolution imaging via 3D Structured Illumination microscopy (3D-SIM), the DeltaVision OMX V4 Blaze was used (GE Healthcare). Samples were excited using 488, 568 or 642 nm lasers and imaged using band pass filters at 528/48, 609/37 and 683/40 nm with a 60X Olympus Plan APO N (1.42 NA) oil immersion lens. Images were processed using the Fiji ImageJ software [45].

Solubility studies

For the solubility assay, a culture enriched in gametocytes from stage III to stage V was magnet purified. Gametocytes were lysed in 0.03% saponin and the pellet fractions incubated with 0.1 M sodium carbonate, pH 11 (4°C) or in 8 M urea (RT) or 1% Triton X-100 in PBS, pH 7.4 (4°C) or in 2% SDS (RT) for 30 min. The soluble supernatant and the insoluble pellet were collected and taken up in 1x SDS loading buffer. Proteins fractions were analysed by immunoblotting.

Immunoblotting

For SDS-PAGE, protein samples were prepared by lysis with 0.03% saponin for 25 min on ice. Protein samples were separated on 4–12% Bolt Bis-Tris gels (Invitrogen) and transferred to 0.2 μm nitrocellulose membrane using the iBlot system (Invitrogen). The nitrocellulose membrane was blocked in 3.5% skim milk/1xPBS for 1 h at RT prior to antibody probing. Primary and secondary antibodies were prepared in 3.5% skim milk and incubated with the membranes for 1 h at RT. The membranes were washed with 1x PBS/0.05% Tween20 after the primary and secondary antibody incubations. The following primary antibodies were used in this study: anti-PhIL1 pre/post-immune (1:500), anti-HA mouse (1:500, Sigma Aldrich), anti-ERC (1:1000), anti-GAP45 (1:1000, [44]), anti-GAP50 (1:500, [44], anti-GFP, 1:500, Roche)). Horseradish peroxidase conjugated anti-mouse or anti-rabbit antibodies were used (1:25,000, Millipore). The washed immunoblots were incubated with enhanced chemiluminescent (ECL) reagents before being imaged using the FujiFilm LAS3000 digital imaging system (GE Healthcare).

Electron microscopy-high pressure freezing/Freeze substitution

Gametocytes were fixed using 2% paraformaldehyde and 0.1% glutaraldehyde. Cells were mounted to membrane carriers (Leica Microsystems) with a cell depth of 200 μm. The cells were then rapidly frozen by liquid nitrogen jet under 2100 bar pressure in a high pressure freezer (EM PACT2, Leica Microsystems) and quickly transferred to liquid nitrogen. A quick freeze substitution method was used (McDonald and Webb, 2011). The samples were transferred to cryotubes containing fixative: 1% osmium tetroxide, 0.5% uranyl acetate 5% water in acetone at liquid nitrogen temperature. The cryotubes were mounted on a cooled aluminum heat block in a polystyrene box filled with liquid nitrogen. To initiate the freeze substitution, the liquid nitrogen was replaced with dry ice pellets. The box was placed on a rotary shaker at 125 rpm. The dry ice was removed after 2 h and the shaking continued. After 1 h the cryotubes were removed from the block.

Transmission electron microscopy

The samples were washed three times with pure acetone after returning to RT. They were then infiltrated and embedded with EPON resin. Polymerization of the resin was carried out at 60°C before 60 nm sections were prepared with an ultramicrotome (Leica EM UC7, Leica Microsystems). The specimens were post-stained with 7% uranyl acetate in methanol and Reynold’s lead citrate. Samples were observed on Transmission Electron Microscope (TEM) at 200 kV (Tecnai G2 F30, FEI).

Serial block face-scanning electron microscopy (SBF-SEM)

The staining method (ROTO) was adapted from a previous publication [46]. Parasite pellets were fixed with 2.5% glutaraldehyde in PBS for 1 h at 4°C. Following agarose pre-embedding and washing with 0.175 M sodium cacodylate buffer, cells were stained in ferrocyanide-reduced osmium tetroxide in 0.1 M cacodylate buffer for 1 h on ice. After washing with double distilled H₂O, the cells were incubated with freshly prepared 1% thiocarbonhydrazide solution in H₂O for 20 min at RT. The cells were then rinsed and further stained with 2% osmium tetroxide in H₂O for 30 min at RT. Subsequently the cells were rinsed and en-bloc stained with 1% uranyl acetate in H₂O overnight at RT. In the final step of staining the specimens were rinsed and treated en-bloc with Walton’s lead aspartate for 30 min at 60°C [47]. Following the removal of lead aspartate and several washes, the cells were dehydrated in a graded series of ethanol-H₂O mixes, followed by several washes in dry ethanol and dry acetone and then progressively infiltrated with EPON resin. After resin polymerization, a 200 x 200 x 200 μm resin block was trimmed off using the mesa trimming method [48] on an ultramicrotome (Leica EM UC7, Leica Microsystems). The resin block was mounted on a microtome stub and immobilized using silver glue. After the silver glue was completely dried, the resin block was coated with a layer of gold and the top surface was then cleansed by diamond knife. The serial images (every 50 nm) were collected by a serial block face-scanning electron microscope (SEM), which was equipped with an in-chamber diamond knife, (Teneo VolumeScope, FEI Company) using back scattered electron signals at 3 kV under low vacuum conditions.

SBF-SEM image analysis

Serial sections were optimized and aligned using IMOD software (Boulder Laboratory for 3D Electron Microscopy of Cells). The regions of interest were segmented and reconstructed into 3D models, using a semi-automatic method described previously [49]. Briefly, the pixel size of the greyscale images was binned to 20–50 nm, the images were subjected to Gaussian smoothing and a threshold value was selected manually from each reconstructed tomogram using a noise-estimate variance criterion, after marking some of the relevant cellular features, as described by others [50]. Connected regions were identified semi-automatically using connected component analysis [51]. Where required, a rough bounding area was drawn manually on every a few 2D sections. The regions were labeled with different colors, and 3D models were generated and rendered [52]. The volumes of the 3D models were determined for the organelles, while the parasite volume was determined after manual segmentation.

For polarity assessment, the IMOD Slicer tool was used to orient slices at the maximum length or width of the cells and organelles and the relative distances from the ends were measured using open contours in IMOD. The correct positioning of the open contours was confirmed on 3D models.

Immunoprecipitation and mass spectrometry

Purified gametocytes were harvested and washed in 1xPBS for co-immunoprecipitation experiments. Parasites were solubilized using 1% TX-100/PBS (in 150 mM NaCl, 50 mM Tris, 2 mM EDTA) plus Complete protease inhibitors (Roche) on ice for 30 min, re-suspending every 10 min. Insoluble material was pelleted by centrifugation 16,000 x g for 10 min at 4°C. The supernatant was also re-pelleted to remove any residual insoluble material. The soluble fraction was incubated with 50 μL of Pierce protein A agarose beads (Pierce) for 30 min at 4°C to remove non-specific binding proteins. The resin was pelleted by centrifugation at 3,420 x g for 2 min and supernatant was incubated for 2 h with 25 μL GFP-Trap A (Chromotek) or anti-HA agarose (Sigma) depending on parasite cell line, at 4°C. After pelleting the resin at 3,420 g for 2 min, the beads were washed five times with 1% Triton X-100. Proteins were then either eluted using SDS and analysed via Western blotting or the beads were washed two times with 1 mM Tris and analysed via mass spectrometry.

For mass spectrometry, proteins was eluted from beads with 5 μL trifluroethanol and 20 μL 0.1% formic acid (pH 2.5) and incubated at 50°C for 5 min. Beads were pelleted at 3,420 x g for 2 min and 20 μL of the supernatant collected. The sample was neutralized with the addition of 1 μL of 1 M tetraethylammonium bicarbonate. To reduce disulphide bonds, 0.2 μL of tris(2-carboxyethyl)phosphine (final concentration of 5 mM) was added to the supernatant and the solution was incubated at 70°C for 10 min. Proteins were digested with trypsin overnight at 37°C. Mass spectrometry was performed using a Thermo NanoLC/ OrbiTRAP ELITE ETD for GFP-Trap samples, and a Thermo NanoLC/ Q Exactive Plus for the anti-HA Agarose samples. Mass spectra were searched in MASCOT (Matrix Science) against a custom database comprised of P. falciparum (PlasmoDB) and H. sapiens (UniProt) non-redundant proteomes. Protein hits were considered significant if they were present in two biological replicates, had ≥2 significant peptide MS/MS spectra, and were at least 5 times enriched compared to the 3D7 or NF54 parental control. The mass spectrometry proteomics data have been deposited to the ProteomeXchange Consortium via the PRIDE [53] partner repository with the dataset identifier PXD007564.

Quantification and statistical analysis

All statistical analyses were performed using the Graph Pad Prism 5 software package. P values were calculated using an unpaired t-test, the mean values plus or minus the standard error are shown. This information is provided in the figure legends. The numbers of repeat experiments, internal replicates and cell numbers measured are noted in the figure legends.

Ethics statement

Red Blood Cells and serum was obtained from the Australian Red Cross blood service. All blood products were anonymous and individual donors could not be identified. This work was approved by the University of Melbourne Human Research Ethics Committee (Approval number 1135799).